Latest News
Pershing Square founder Bill Ackman is reportedly planning a new hedge fund strategy designed to capitalise on investor complacency, echoing the “doomsday” trades that netted Pershing Square billions during the pandemic, according to a report by the Financial Times.
JPMorgan analysts expect a near-term tailwind for equity markets as macro hedge funds begin rebuilding equity exposure after a sharp reduction in risk during March’s market volatility’s according to a report by Investing.com.
The size of Ireland’s €400bn hedge fund industry means it is unlikely to pose a systemic threat on its own, though risks could emerge through international linkages and correlated trading strategies, according to a report by the Independent citing analysis by the Central Bank of Ireland.
Global equity markets have extended gains following easing geopolitical tensions, with analysts pointing to an additional driver behind the rally: forced short covering by hedge funds after a period of aggressive de-risking, according to a report by Bloomberg citing data from Goldman Sachs.
Franklin Templeton is stepping up its push into alternative investments, expanding its hedge fund and private markets platform as part of a broader strategy to move beyond traditional asset management and deepen its exposure to non-public and liquid alternatives, according to a report by The Street.
Brazil’s hedge fund industry suffered its weakest monthly performance in six years in March, as a sharp repricing in global interest rates – driven by surging energy prices – unravelled widely held macro positions across local managers, according to a report by Bloomberg.
Zaheer Ebtikar, founder of the digital assets hedge fund Split Capital, is winding down the firm as he transitions into the stablecoin sector, joining Plasma, a startup focused on stablecoins, as chief strategy officer, according to a report by Fortune.
Activist investor Shah Capital has announced its intention to vote against the re-election of Novavax’s board members and its executive compensation plan at the biotech’s forthcoming annual meeting, escalating pressure on the vaccine maker for strategic changes, according to a. Report by Reuters.
The dispersion trade, a popular options strategy that profits from differences between individual stock volatility and index volatility, posted its worst monthly performance since 2011 in March, according to a report by Bloomberg.